What's Happening?
Danone Ventures, the venture capital arm of Danone, has invested in French startup Standing Ovation as part of its Series B funding round. This investment aims to accelerate the commercial rollout of Standing Ovation's animal-free dairy proteins, starting
with the U.S. market. Standing Ovation specializes in producing caseins through precision fermentation, creating proteins that are structurally identical to those derived from livestock. The funding round raised a total of $34.2 million, with contributions from Bpifrance and Crédit Mutuel Innovation. The company plans to expand its market reach to Europe and Asia by the end of 2027.
Why It's Important?
This investment by Danone highlights the growing interest and investment in sustainable and innovative food technologies. As consumer demand for plant-based and animal-free products increases, companies like Standing Ovation are positioned to lead the shift towards more sustainable protein production. The collaboration between traditional dairy giants and innovative startups signifies a broader industry trend towards integrating deep tech with agri-food expertise. This move could potentially reshape the dairy industry by providing environmentally friendly alternatives to traditional dairy products, meeting the rising global demand for sustainable food sources.
What's Next?
Standing Ovation plans to use the funds to commercialize its proteins in the U.S., followed by expansions into Europe and Asia. The company will continue to partner with established fermentation manufacturers rather than investing in its own production facilities. This strategy allows for a more flexible and scalable approach to production. As the company progresses, it may face challenges related to regulatory approvals and consumer acceptance in different markets. However, with backing from major industry players like Danone and Bel Group, Standing Ovation is well-positioned to navigate these challenges and drive industry-wide adoption of sustainable proteins.
